Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-06 @ 9:24 AM
Study NCT ID:
NCT03274258
Status:
TERMINATED
Last Update Posted:
2025-12-03
First Post:
2017-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-05
First Submit QC Date:
None
Study First Post Date:
2017-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED